Return to homepagePandemic Pact

Control Studio of 5-lipossigenase in Covid-19 patient samples: development of a new biomarker with promising therapeutic relapses. Control: Covid-19 Inflammation Therapeutic Potential

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:1 publications

Grant number: FISR2020IP_03845

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $67,690.4

  • Funder

    Ministry of Education, University and Research Italy

  • Principal Investigator

    N/A

  • Research Location

    Italy

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.